Athens Medical C.S.A. Stocks

1.75Last Updated 09.04.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

€ 178.06M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
1.75
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Athens Medical C.S.A., together with its subsidiaries, owns and operates hospital units in Greece and internationally. The company offers diagnosis and treatment for breast, gastrointestinal, hematologic, liver and pancreatic, lungs, prostate, skin, bladder and kidney, and gynecological cancers; and robotic, and neurosurgeons and spine surgery services, as well as treatments for heart diseases. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions. In addition, the company operates wellness and prevention centers; and offers cosmetic and reconstructive plastic surgery services. Further, it provides medical education, training, and practice services, as well as guidance for patient care. The company owns and operates 8 hospital units with a total of 1,200 beds. Athens Medical C.S.A. was founded in 1984 and is headquartered in Athens, Greece.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is neutral on EV/EBITDA, reasonabl

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks